Just wondering here. Like quite a few people who
Post# of 148248
Even lately, it's taken the FDA an unconscionably long time to help Dr. Jay put together a protocol for the Colorectal cancer trial. Have they been dragging their feet (still)?
Perhaps this good result can go a long way toward winning over the agency -- or even putting pressure on it to let Leronlimab prove itself in OTHER indications.
Maybe this result will be the snowball that gathers weight as it rolls.
Okay, now I sound like MGK. But you get what I mean.